CELLINK AB (“CELLINK”) has entered an agreement with the owners of cytena GmbH (“cytena”) to acquire all cytena shares for a purchase price of 30.25M euros (“acquisition”). Through cytena’s complementary technology offering, CELLINK sees great synergies that will support future growth. cytena is the company CELLINK announced signing a LOI with in conjunction with raising capital in June this year.
cytena is a life science company focusing on single-cell technologies. cytena was founded in 2014 within the Institute for Microsystems Technology (IMTEK) at the University of